医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2014年
10期
54-55
,共2页
张正培%苗培建%李甦雁%刘海洋%季苏娟
張正培%苗培建%李甦雁%劉海洋%季囌娟
장정배%묘배건%리소안%류해양%계소연
早产儿%视网膜病变%筛查
早產兒%視網膜病變%篩查
조산인%시망막병변%사사
Retinopathy of prematurity%retinopathy%screening
目的:了解徐州地区早产儿视网膜病变(ROP)的患病情况并分析相关因素。方法收集2011.06~2013.06在我院进行视网膜病变筛查和治疗的260例(520只眼)早产儿和低体重儿ROP筛查资料进行分析。结果260例(520只眼)早产儿和低体重儿中,13例(5.0%)21只眼为 ROP,包括 ROP I期7例10只眼,ROP II期4例7只眼,ROP III期2例4只眼,未发现ROP IV或V期早产儿患儿。7例 ROP I期和4例ROP II期患儿定期复查发现 ROP逐渐消退,2例 ROP III期患儿通过密切观察发现病变已达到阈值期ROP,予玻璃体腔注射Bevacizumab联合光凝治疗,术后效果良好。结论早产、低出生体重及相对缺氧因素是 ROP发生的相关因素。
目的:瞭解徐州地區早產兒視網膜病變(ROP)的患病情況併分析相關因素。方法收集2011.06~2013.06在我院進行視網膜病變篩查和治療的260例(520隻眼)早產兒和低體重兒ROP篩查資料進行分析。結果260例(520隻眼)早產兒和低體重兒中,13例(5.0%)21隻眼為 ROP,包括 ROP I期7例10隻眼,ROP II期4例7隻眼,ROP III期2例4隻眼,未髮現ROP IV或V期早產兒患兒。7例 ROP I期和4例ROP II期患兒定期複查髮現 ROP逐漸消退,2例 ROP III期患兒通過密切觀察髮現病變已達到閾值期ROP,予玻璃體腔註射Bevacizumab聯閤光凝治療,術後效果良好。結論早產、低齣生體重及相對缺氧因素是 ROP髮生的相關因素。
목적:료해서주지구조산인시망막병변(ROP)적환병정황병분석상관인소。방법수집2011.06~2013.06재아원진행시망막병변사사화치료적260례(520지안)조산인화저체중인ROP사사자료진행분석。결과260례(520지안)조산인화저체중인중,13례(5.0%)21지안위 ROP,포괄 ROP I기7례10지안,ROP II기4례7지안,ROP III기2례4지안,미발현ROP IV혹V기조산인환인。7례 ROP I기화4례ROP II기환인정기복사발현 ROP축점소퇴,2례 ROP III기환인통과밀절관찰발현병변이체도역치기ROP,여파리체강주사Bevacizumab연합광응치료,술후효과량호。결론조산、저출생체중급상대결양인소시 ROP발생적상관인소。
Objective To study the prevalence of retinopathy prematurity (ROP)in preterm infants in Xuzhou and analysis the risk factors for ROP. Methods A analysis was conducted on 260(520 eyes) premature infants from June 2011 to June 2013. Results In al the infants examined, 21 eyes of 13 cases (5.0%) developed ROP. ROP I included ten eyes of seven cases, ROP II included seven eyes of four cases, ROP III included four eyes of two cases, was not found developed ROP IV or V of preterm infants. Seven cases of ROP I and four cases of ROP II periodic review found that faded ROP. ROP with stage III disease through close observation that has reached the threshold of ROP, intravitreal injection of Bevacizumab combined to photocoagulation therapy, postoperative good results. Conclusion Prematurity, low birth weight and the relative hypoxia are risk factors for the occurrence of ROP.